“…Warfarin, brodifacoum, dicumarol, coumatetralyl, coumafuryl, and difenacoum are well-known examples of current drugs molecules that possess 4-hydroxy coumarin as a core structural moiety. − Moreover, wedelolactone, coumestrol, and neo-tanshinlactone are emerging potential candidates to this end that revealed promising activities (Figure ). , Recently, trans -2,3-dihydrofuro[3,2- c ]coumarins (DHFCs) (derivatives of 4-hydroxy coumarin) are of great interest among coumarins possessing a unique 4 H -furo ring fused with coumarin, which are well-known for their medicinal importance, therapeutic activities, and applications in myriad pharmaceutical ingredients. , Several drug candidates containing the furo[3,2- c ]coumarin and DHFC skeleton display an extremely wide range of biological activities such as anticoagulant, antibacterial, antifungal, antitumor, antiviral, anticonvulsant, anticancer, antimicrobial, antiprotozoal, insecticidal, fungicidal, antimycobacterial, antimutagenic, antioxidant, and anti-inflammatory. − For instance, natural products austocystin A and D and neo-tanshinlactone isolated from the maize meal cultures of Aspergillus ustus and Salvia miltiorrhiza, respectively, displayed potent antitumor activities and cytotoxicity against breast cancer. , In addition, naphthalene-functionalized DHFCs are known as antioxidant and anthelmintic agents …”